Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
Tags
astrazeneca
17
×
national blog main
life sciences
texas blog main
biotech
texas top stories
national top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
boston top stories
fda
startups
clinical trials
pfizer
abbvie
cancer
deals
merck
novartis
amgen
bristol-myers squibb
cancer immunotherapy
What
bio
roundup
conference
drug
cancer
news
raised
week
acquisitions
alzheimer’s
amid
annual
biotech
bombast
caught
ceo
coronavirus
daniel
debate
develop
discussion
drugs
efforts
esmo
fda
gilead
help
ipo
medical
meso’s
miss
new
onconano
opioid
o’day
pandemic
pfizer’s
plans
presidential
prices
Language
unset
Current search:
astrazeneca
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
New Funds for Procyrion, Remedy, OncoNano, Vyopta & More TX Tech
@xconomy.com
5 years ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
RiverVest Venture Closes $184M Fund for Backing Healthcare Ventures
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
6 years ago
OncoNano, Maker of Tumor Imaging Technology, Raises $11.7 Million
@Murph_CJ
7 years ago
RT @DrWeidner: AstraZeneca plans new connected inhaler trial to improve medication adherence in COPD patients | #digitalhealth http://mobihealthnews.com/content/astrazeneca-plans-new-connected-inhaler-trial-improve-medication-adherence-copd-patients